Related Experiment Video
Updated: May 5, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
National BVDV eradication programme: Assessing the utility of the spot test
George L Caldow1, Helen Carty2, John Berezowski3
1Scotland's Rural College, Veterinary Services, Greycrook, St Boswells TD6 0EU, UK.
None:
We examined the BVDV test records of 3769 farm holdings from one laboratory involved in a national BVDV eradication programme with the objectives (1) to investigate the utility of the spot test to identify BVDV infected herds correctly; (2) to explore the possible reasons for false positive results and (3) to examine the frequency with which herds subsequently had a BVDV persistently infected (PI) calf born. During the 12-month study, 283 (7.5%) farm holdings were identified as BVD not negative based on the presence of antibodies to BVDV. Follow-up testing was carried out in 131 (3.5%) and in 79 (2.1%) of those, results were not consistent with BVDV infection. The main cause of false positive spot tests was transient antibodies in animals younger than 270 days of age, consistent with the persistence of maternally derived antibodies. BVDV PI births were found on 34 farm holdings (0.9%), in herds that were identified by the spot test as BVD not negative, as well as in herds identified as BVD negative. Farm holdings with spot tests with more than 40% of the samples positive for antibody and those with more than 20% and less than 40% were, respectively, 27.7 and 25.0 times more likely to have a PI born than those that had a negative spot test. However, farm holdings with at least one positive, but no more than 20% of the samples positive for antibody, were 3.9 times more likely to have a PI born than those in which no antibody positive animals were detected. We concluded that ignoring the presence of single antibody positives in the spot test could be counterproductive to the objective of national BVDV eradication.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
11:28Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015